Janet Woodcock says FDA focused on accessible coronavirus testing products

Food and Drug Administration Acting Commissioner Janet Woodcock testifies at Senate HELP Committee hearing on coronavirus pandemic response that dynastic tests were a key line of defense in the pandemic it will become increasingly important, increasing access to accurate rapid at home tests a priority for FDA, the agency authorizing additional over the counter at home tests expected to significantly increase, authorizations adding to a growing list of tests that could be used at home without a prescription in the US, providing recommendations for labeling updates to facilitate better over the counter single use testing for systematic people, change allowing the tests to be sold a single test meeting greater availability.